Tilray Brands, Inc. Other Comprehensive Income (Loss), Net of Tax
Tilray Brands, Inc. (TLRY) reported Other Comprehensive Income (Loss), Net of Tax of $430.00 thousand for the 12-month period ending 2025-05-31, per its 10-K filed 2025-07-29.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2025-07-29
- Tilray Brands, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-05-31 was $10.63M.
- Tilray Brands, Inc. other comprehensive income (loss), net of tax for the quarter ending 2025-02-28 was -$5.39M.
- Tilray Brands, Inc. other comprehensive income (loss), net of tax for the quarter ending 2024-11-30 was -$8.97M, a 272.32% decline year-over-year.
- Tilray Brands, Inc. other comprehensive income (loss), net of tax for the quarter ending 2024-08-31 was $4.16M, a 29.64% increase year-over-year.
- Tilray Brands, Inc. other comprehensive income (loss), net of tax for fiscal 2025 was $430.00K, a 86.22% decline from fiscal 2024.
- Tilray Brands, Inc. other comprehensive income (loss), net of tax for fiscal 2024 was $3.12M.
- Tilray Brands, Inc. other comprehensive income (loss), net of tax for fiscal 2023 was -$8.36M.
- Tilray Brands, Inc. other comprehensive income (loss), net of tax for fiscal 2022 was -$196.73M, a 228.73% decline from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2025-05-31 | $10.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $5.24M derived: sum of 2 quarters · filed 2025-07-29 | -$3.73M derived: sum of 3 quarters · filed 2025-07-29 | $430.00K 10-K · filed 2025-07-29 |
| 2025-02-28 | -$5.39M 10-Q · filed 2025-04-08 | -$14.36M derived: sum of 2 quarters · filed 2025-04-08 | -$10.20M 10-Q · filed 2025-04-08 | -$10.79M derived: sum of 4 quarters · filed 2025-07-29 |
| 2024-11-30 | -$8.97M 10-Q · filed 2025-01-10 | -$4.81M 10-Q · filed 2025-01-10 | -$5.40M derived: sum of 3 quarters · filed 2025-07-29 | -$10.10M derived: sum of 4 quarters · filed 2025-07-29 |
| 2024-08-31 | $4.16M 10-Q · filed 2024-10-10 | $3.56M derived: sum of 2 quarters · filed 2025-07-29 | -$1.13M derived: sum of 3 quarters · filed 2025-07-29 | $4.07M derived: sum of 4 quarters · filed 2025-07-29 |
| 2024-05-31 | -$595.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | -$5.29M derived: sum of 2 quarters · filed 2025-07-29 | -$88.00K derived: sum of 3 quarters · filed 2025-07-29 | $3.12M 10-K · filed 2025-07-29 |
| 2024-02-29 | -$4.70M 10-Q · filed 2025-04-08 | $507.00K derived: sum of 2 quarters · filed 2025-04-08 | $3.72M 10-Q · filed 2025-04-08 | -$1.32M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-11-30 | $5.20M 10-Q · filed 2025-01-10 | $8.41M 10-Q · filed 2025-01-10 | $3.38M derived: sum of 3 quarters · filed 2025-07-29 | $105.11M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-08-31 | $3.21M 10-Q · filed 2024-10-10 | -$1.82M derived: sum of 2 quarters · filed 2025-07-29 | $99.91M derived: sum of 3 quarters · filed 2025-07-29 | $57.67M derived: sum of 4 quarters · filed 2025-07-29 |
| 2023-05-31 | -$5.03M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-29 | $96.70M derived: sum of 2 quarters · filed 2025-07-29 | $54.46M derived: sum of 3 quarters · filed 2025-07-29 | -$8.36M 10-K · filed 2025-07-29 |
| 2023-02-28 | $101.73M 10-Q · filed 2024-04-09 | $59.49M derived: sum of 2 quarters · filed 2024-04-09 | -$3.32M 10-Q · filed 2024-04-09 | -$29.16M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-11-30 | -$42.24M 10-Q · filed 2024-01-09 | -$105.06M 10-Q · filed 2024-01-09 | -$130.90M derived: sum of 3 quarters · filed 2024-10-10 | -$151.70M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-08-31 | -$62.82M 10-Q · filed 2024-10-10 | -$88.66M derived: sum of 2 quarters · filed 2024-10-10 | -$109.46M derived: sum of 3 quarters · filed 2024-10-10 | -$158.13M derived: sum of 4 quarters · filed 2024-10-10 |
| 2022-05-31 | -$25.84M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-30 | -$46.64M derived: sum of 2 quarters · filed 2024-07-30 | -$95.31M derived: sum of 3 quarters · filed 2024-07-30 | -$196.73M 10-K · filed 2024-07-30 |
| 2022-02-28 | -$20.80M 10-Q · filed 2023-04-10 | -$69.47M derived: sum of 2 quarters · filed 2023-04-10 | -$170.89M 10-Q · filed 2023-04-10 | -$11.19M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-11-30 | -$48.67M 10-Q · filed 2023-01-09 | -$150.09M 10-Q · filed 2023-01-09 | $9.61M derived: sum of 3 quarters · filed 2023-07-26 | $2.26M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-08-31 | -$101.42M 10-Q · filed 2022-10-07 | $58.28M derived: sum of 2 quarters · filed 2023-07-26 | $50.93M derived: sum of 3 quarters · filed 2023-07-26 | $50.02M derived: sum of 4 quarters · filed 2023-07-26 |
| 2021-05-31 | $159.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-26 | $152.35M derived: sum of 2 quarters · filed 2023-07-26 | $151.44M derived: sum of 3 quarters · filed 2023-07-26 | $152.82M 10-K · filed 2023-07-26 |
| 2021-02-28 | -$7.35M 10-Q · filed 2022-04-06 | -$8.26M derived: sum of 2 quarters · filed 2022-04-06 | -$6.88M 10-Q · filed 2022-04-06 | |
| 2020-11-30 | -$910.00K 10-Q · filed 2022-01-10 | $475.00K 10-Q · filed 2022-01-10 | ||
| 2020-08-31 | $1.39M 10-Q · filed 2021-10-07 | |||
| 2020-05-31 | -$6.33M 10-K · filed 2022-07-28 | |||
| 2019-12-31 | $5.15M 10-K · filed 2021-02-19 | |||
| 2019-05-31 | -$2.66M 10-K · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |